DC Field | Value | Language |
---|---|---|
dc.contributor.author | Young Do Yoo | - |
dc.contributor.author | H Ueda | - |
dc.contributor.author | Keunchil Park | - |
dc.contributor.author | K C Flanders | - |
dc.contributor.author | Young Ik Lee | - |
dc.contributor.author | G Jay | - |
dc.contributor.author | Seong-Jin Kim | - |
dc.date.accessioned | 2017-04-19T08:45:14Z | - |
dc.date.available | 2017-04-19T08:45:14Z | - |
dc.date.issued | 1996 | - |
dc.identifier.issn | 0021-9738 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/3676 | - |
dc.description.abstract | TGF-β1 has been implicated in the pathogenesis of liver disease. The high frequency of detection of the hepatitis B virus X (HBx) antigen in liver cells from patients with chronic hepatitis, cirrhosis, and liver cancer suggested that expression of HBx and TGF-β1 may be associated. To test this possibility, we examined the expression of TGF-β1 in the liver of transgenic mice expressing the HBx gene. We show that the patterns of expression of TGF-β1 and Hbx protein are similar in these mice and that HBx activates transcription of the TGF-β1 gene in transfected hepatoma cells. The cis-acting element within the TGF-β1 gene that is responsive to regulation by Hbx is the binding site for the Egr family of transcription factors. We further show that the Egr-1 protein associates with the HBx protein, allowing HBx to participate in the transcriptional regulation of immediate-early genes. Our results suggest that expression of Hbx might induce expression of TGF-β1 in the early stages of infection and raise the possibility that TGF-ßl may play a role in hepatitis B virus pathogenesis. | - |
dc.publisher | Amer Soc Clinical Investigation Inc | - |
dc.title | Regulation of transforming growth factor-β1 expression by the hepatitis B virus(HBV) X transactivator : role in HBV pathogenesis | - |
dc.title.alternative | Regulation of transforming growth factor-β1 expression by the hepatitis B virus(HBV) X transactivator : role in HBV pathogenesis | - |
dc.type | Article | - |
dc.citation.title | Journal of Clinical Investigation | - |
dc.citation.number | 2 | - |
dc.citation.endPage | 395 | - |
dc.citation.startPage | 388 | - |
dc.citation.volume | 97 | - |
dc.contributor.affiliatedAuthor | Young Ik Lee | - |
dc.contributor.alternativeName | 유영도 | - |
dc.contributor.alternativeName | Ueda | - |
dc.contributor.alternativeName | 박근칠 | - |
dc.contributor.alternativeName | Flanders | - |
dc.contributor.alternativeName | 이영익 | - |
dc.contributor.alternativeName | Jay | - |
dc.contributor.alternativeName | 김성진 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Investigation, vol. 97, no. 2, pp. 388-395 | - |
dc.identifier.doi | 10.1172/JCI118427 | - |
dc.subject.keyword | hepatitis B virus | - |
dc.subject.keyword | hepatocellular carcinoma | - |
dc.subject.keyword | immunohistochemistry | - |
dc.subject.keyword | TGF-β1 | - |
dc.subject.keyword | transcription | - |
dc.subject.local | Hepatitis B Virus | - |
dc.subject.local | Hepatitis B virus | - |
dc.subject.local | Hepatitis B virus (HBV) | - |
dc.subject.local | hepatitis B Virus (HBV) | - |
dc.subject.local | hepatitis B virus | - |
dc.subject.local | hepatitis B virus (HBV) | - |
dc.subject.local | Hepatocellular carcinoma | - |
dc.subject.local | Hepatocellular carcinoma (HCC) | - |
dc.subject.local | Hepatocellular carcinomas | - |
dc.subject.local | hepatocellular carcinoma | - |
dc.subject.local | hepatocellular carcinoma (HCC) | - |
dc.subject.local | Immunohistochemistry | - |
dc.subject.local | immunohistochemistry | - |
dc.subject.local | immunohistochimistry | - |
dc.subject.local | TGF-β1 | - |
dc.subject.local | TGFβ-1 | - |
dc.subject.local | Transcription | - |
dc.subject.local | transcription | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.